Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Other solid neoplasm 1 Other hematologic neoplasm 1 Gynecologic 1 Gastrointestinal 1

Conditions

Ovarian Carcinosarcoma 1

Interventions

Specimen Handling 27 Magnetic Resonance Spectroscopy 23 Cyclophosphamide 16 Biopsy 16 Doxorubicin 13 pembrolizumab 11 Temozolomide 11 X-Rays 10 Radiation 10 atezolizumab 8 Radiotherapy 8 Irinotecan 8 Phantoms, Imaging 7 Nivolumab 7 fludarabine 6 Vincristine 6 Immunoglobulin G 6 Etoposide 6 Bevacizumab 6 liposomal doxorubicin 5 cemiplimab 5 cabozantinib 5 Sirolimus 5 Ifosfamide 5 Gemcitabine 5 Disulfides 5 palbociclib 4 olaparib 4 fludarabine phosphate 4 Surgical Procedures, Operative 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Antineoplastic Agents × Sarcoma × 30 days × Clear all

NCT03651206 2026-06-01

ROCSAN

ARCAGY/ GINECO GROUP

Phase 2/3 Recruiting

GynecologicSarcoma

Ovarian Carcinosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡